ICMR partners with industry leaders for groundbreaking First-in-Human Phase-1 clinical trials, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

ICMR will engage in collaborative research on a small molecule for multiple myeloma with Aurigene Oncology Limited, partner with Indian Immunologicals Limited for the development of a Zika vaccine, coordinate a seasonal influenza virus vaccine trial with Mynvax Private Limited, and advance CAR-T cell therapy for a new indication of chronic lymphocytic leukemia in collaboration with ImmunoACT., ICMR will engage in collaborative research on a small molecule for multiple myeloma with Aurigene Oncology Limited, partner with Indian Immunologicals Limited for the development of a Zika vaccine, coordinate a seasonal influenza virus vaccine trial with Mynvax Private Limited, and advance CAR-T cell therapy for a new indication of chronic lymphocytic leukemia in collaboration with ImmunoACT., , Read More

Leave a Reply

Your email address will not be published. Required fields are marked *